The Bio Even milestones
September 2021
Bioeven is preparing for the Second in vivo publication with Jolanda Spadavecchia and Xiaowu Li
July 2021
We are very excited to annonce that Our scientific committee has decided to establish an Open international Laboratory between Shenzhen University in China, Paris Sorbonne University in paris France and institute Mario Negri, San Raffaele Scientific Institute in Milan Itlay. This collaboration will bring a very bright future for Bioeven
May 2020
The invention relates to Flavin Adenine Dinucleotide (FAD) for use in the prevention and/or treatment of cancer
Advantageously, the FAD is at least partially encapsulated in a particle with a vector for improving the adsorption thereof and the distribution thereof while at the same time limiting the destruction thereof, in particular by blood hydrolases. The invention is part of the pharmaceutical field and more specifically oncology or cancerology.
January 2020
Bio Even becomes a member of France Biotech
France Biotech, fondée en 1997, est une association indépendante qui fédère les entrepreneurs de l’innovation dans la santé et leurs partenaires experts. Animateur de l’écosystème de l’innovation en santé et interlocuteur privilégié des pouvoirs publics, France Biotech contribue à relever les défis du secteur HealthTech et à proposer des solutions concrètes, en termes de compétitivité et d’attractivité, par l’intermédiaire de ses 9 commissions et 3 groupes de travail.